INDUSTRY × Myelodysplastic-Myeloproliferative Diseases × Lymphoid × Clear all Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Phase 1 Recruiting
100 enrolled
AZURE
Phase 1 Terminated
9 enrolled